These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 24059318)

  • 1. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
    Zemva J; Schubert M
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):322-37. PubMed ID: 24059318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease.
    Freude S; Hettich MM; Schumann C; Stöhr O; Koch L; Köhler C; Udelhoven M; Leeser U; Müller M; Kubota N; Kadowaki T; Krone W; Schröder H; Brüning JC; Schubert M
    FASEB J; 2009 Oct; 23(10):3315-24. PubMed ID: 19487308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance.
    Gontier G; George C; Chaker Z; Holzenberger M; Aïd S
    J Neurosci; 2015 Aug; 35(33):11500-13. PubMed ID: 26290229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia.
    Zemva J; Schubert M
    Curr Diabetes Rev; 2011 Sep; 7(5):356-66. PubMed ID: 21916834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease.
    Freude S; Schilbach K; Schubert M
    Curr Alzheimer Res; 2009 Jun; 6(3):213-23. PubMed ID: 19519303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.
    Moloney AM; Griffin RJ; Timmons S; O'Connor R; Ravid R; O'Neill C
    Neurobiol Aging; 2010 Feb; 31(2):224-43. PubMed ID: 18479783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Reduction of Insulin Signaling Mitigates Amyloid-β Deposition by Promoting Expression of Extracellular Matrix Proteins in the Brain.
    Sano T; Ochiai T; Nagayama T; Nakamura A; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
    J Neurosci; 2023 Oct; 43(43):7226-7241. PubMed ID: 37699718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease.
    Stöhr O; Schilbach K; Moll L; Hettich MM; Freude S; Wunderlich FT; Ernst M; Zemva J; Brüning JC; Krone W; Udelhoven M; Schubert M
    Age (Dordr); 2013 Feb; 35(1):83-101. PubMed ID: 22057897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease.
    Ochiai T; Sano T; Nagayama T; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
    Neurobiol Dis; 2021 Nov; 159():105510. PubMed ID: 34537327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
    de la Monte SM
    Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models.
    Zhang B; Tang XC; Zhang HY
    J Neurosci Res; 2013 May; 91(5):717-25. PubMed ID: 23401344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible usefulness of growth hormone/insulin-like growth factor-I axis in Alzheimer's disease treatment.
    Sáez JM
    Endocr Metab Immune Disord Drug Targets; 2012 Sep; 12(3):274-86. PubMed ID: 22524398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
    de la Monte SM; Tong M; Schiano I; Didsbury J
    J Alzheimers Dis; 2017; 55(2):849-864. PubMed ID: 27802237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease.
    O'Neill C; Kiely AP; Coakley MF; Manning S; Long-Smith CM
    Biochem Soc Trans; 2012 Aug; 40(4):721-7. PubMed ID: 22817723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco Smoke Exposure Impairs Brain Insulin/IGF Signaling: Potential Co-Factor Role in Neurodegeneration.
    Deochand C; Tong M; Agarwal AR; Cadenas E; de la Monte SM
    J Alzheimers Dis; 2016; 50(2):373-86. PubMed ID: 26682684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
    Talbot K; Wang HY; Kazi H; Han LY; Bakshi KP; Stucky A; Fuino RL; Kawaguchi KR; Samoyedny AJ; Wilson RS; Arvanitakis Z; Schneider JA; Wolf BA; Bennett DA; Trojanowski JQ; Arnold SE
    J Clin Invest; 2012 Apr; 122(4):1316-38. PubMed ID: 22476197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Insulin-Like Growth Factor I is Involved in the Effect of High Fat Diet on Peripheral Amyloid β Clearance.
    Herrero-Labrador R; Trueba-Saiz A; Martinez-Rachadell L; Fernandez de Sevilla ME; Zegarra-Valdivia JA; Pignatelli J; Diaz-Pacheco S; Fernandez AM; Torres Aleman I
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood-Brain Barrier.
    Zhou AL; Swaminathan SK; Salian VS; Wang L; Curran GL; Min HK; Lowe VJ; Kandimalla KK
    Mol Pharm; 2024 May; 21(5):2176-2186. PubMed ID: 38625027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.